MUM1 expression dichotomizes follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes

Haematologica

Volumn 92, Issue 2, 2007, Pages 267-268

  Naresh, Kikkeri N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

B cell; Bcl 2; Bcl 6; CD10; Follicular lymphoma; Germinal center; IRF4; Ki 67; MUM1

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PROTEIN BCL 6; PROTEIN MUM1; UNCLASSIFIED DRUG; BCL6 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; MEMBRANE METALLOENDOPEPTIDASE; PROTEIN BCL 2;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; ONCOGENE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; B LYMPHOCYTE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LETTER; METABOLISM;

B-LYMPHOCYTES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTORS; KI-67 ANTIGEN; LYMPHOMA, FOLLICULAR; NEPRILYSIN; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33947520117     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10682     Document Type: Article

References (10)

1. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226-30.
2. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000;95:2084-92.
3. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I, et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 2000;14:449-56.
4. Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease. Br J Haematol 2002;117:366-72.
5. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-51.
6. Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, et al. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood 2002;100:4671-5.
7. Capello D, Cerri M, Muti G, Berra E, Oreste P, Deambrogi C, et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood 2003;102:3775-85.
8. Jaffe ES, Harris NL, Stein H, et al. World Health Organization of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. 2001.
9. Natkunam Y, Warnke RA, Montgomery K, Falini B, van De Rijn M. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol 2001;14:686-94.
10. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-82.